Clinical Trial: Paclitaxel in Treating Patients With Lung Cancer

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Phase II Study on TAXOL in Bronchioalveolar Carcinoma

Brief Summary:

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of paclitaxel in treating patients who have unresectable stage IIIB, stage IV or recurrent lung cancer.